<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 15.6: Hepatic Insulin Resistance and NAFLD Integration</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE theme for Advanced Pathophysiology */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Highlighting */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 8px;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 24px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f9ff;
            border-radius: 8px;
            color: #1e40af;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fafafa;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #888;
            font-size: 13px;
        }

        @media (max-width: 600px) {
            .toc-list { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 15: Advanced Pathophysiology & Metabolic Complications</p>
            <h1 class="lesson-title">Lesson 15.6: Hepatic Insulin Resistance and NAFLD Integration</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 6 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#overflow"><span class="section-num">1</span>The Overflow Hypothesis</a></li>
                <li><a href="#fructose"><span class="section-num">2</span>Fructose & Uric Acid Dynamics</a></li>
                <li><a href="#biomarkers"><span class="section-num">3</span>ALT/AST & Fatty Liver Index</a></li>
                <li><a href="#choline"><span class="section-num">4</span>Choline & Methionine Export</a></li>
                <li><a href="#defatting"><span class="section-num">5</span>De-fatting the Liver Strategies</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Restoring First-Phase Response</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the "Overflow Hypothesis" of systemic insulin resistance.</li>
                <li>Explain the unique biochemical pathway of fructose metabolism and its link to uric acid.</li>
                <li>Analyze hepatic biomarkers (ALT, AST, GGT) through a metabolic coaching lens.</li>
                <li>Understand the critical role of methyl donors in hepatic triglyceride export.</li>
                <li>Design evidence-based protocols to reverse hepatic steatosis and restore glycemic control.</li>
            </ul>
        </div>

        <h2 id="overflow">1. The 'Overflow Hypothesis': The Liver as a Metabolic Dam</h2>
        <p>In the traditional view of Type 2 Diabetes, we often focus on the pancreas or the muscle. However, the <span class="highlight">S.T.A.B.L.E. Methodâ„¢</span> emphasizes that the liver is the primary "metabolic gatekeeper." The <strong>Overflow Hypothesis</strong> suggests that systemic insulin resistance begins when subcutaneous adipose tissue (the fat under your skin) reaches its maximum storage capacityâ€”a threshold known as the Personal Fat Threshold.</p>

        <p>When these safe storage depots are full, lipids "overflow" into non-adipose tissues. The first and most critical site is the liver. This <span class="highlight">ectopic fat deposition</span> triggers a cascade of local insulin resistance. A 2021 meta-analysis involving over 12,000 participants found that hepatic fat content is a stronger predictor of future T2D than BMI alone (OR 3.45; 95% CI).</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">25%</span>
                    <span class="stat-label">Global NAFLD Prevalence</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">70%</span>
                    <span class="stat-label">T2D Patients with NAFLD</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">2.5x</span>
                    <span class="stat-label">Increased T2D Risk</span>
                </div>
            </div>
        </div>

        <p>Mechanistically, the accumulation of <strong>Diacylglycerols (DAGs)</strong> in the liver activates Protein Kinase C-epsilon (PKC-Îµ). This enzyme inhibits the insulin receptor's ability to signal, effectively "blinding" the liver to insulin. Consequently, the liver continues to produce glucose (gluconeogenesis) even when blood sugar is already high, leading to the chronic hyperglycemia seen in our clients.</p>

        <h2 id="fructose">2. Fructose and Uric Acid: The Hidden Metabolic Saboteurs</h2>
        <p>While glucose can be processed by every cell in the body, <span class="highlight">fructose is almost exclusively metabolized in the liver</span>. Unlike glucose, fructose metabolism lacks a "rate-limiting step." It bypasses the enzyme phosphofructokinase, which usually acts as a brake on energy production.</p>

        <p>This unregulated influx of substrate forces the liver into <strong>De Novo Lipogenesis (DNL)</strong>â€”the creation of new fat from sugar. Furthermore, the rapid phosphorylation of fructose depletes intracellular ATP, leading to the generation of <span class="highlight">uric acid</span>. High uric acid isn't just for gout; it acts as a pro-oxidant within the mitochondria, further driving insulin resistance.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Healthy" Smoothie Habit</p>
                    <p style="color:rgba(255,255,255,0.8); font-size:13px; margin:0;">Client: David, 44 | BMI: 26 (Normal) | HbA1c: 5.9%</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presentation:</strong> David presented with "skinny fat" phenotype and rising fasting glucose (108 mg/dL). He consumed 2 large fruit-based smoothies daily, believing them to be healthy.</p>
                <p><strong>Intervention:</strong> Davidâ€™s uric acid was 7.2 mg/dL (High-normal). We implemented the <strong>Transform Nutrition</strong> pillar of the S.T.A.B.L.E. Method, replacing liquid fructose with whole-food fiber and protein.</p>
                <p><strong>Outcome:</strong> In 8 weeks, David's ALT dropped from 42 to 22 U/L, and his fasting glucose stabilized at 92 mg/dL. His uric acid fell to 5.4 mg/dL.</p>
            </div>
        </div>

        <h2 id="biomarkers">3. Interpreting ALT/AST Ratios and the Fatty Liver Index</h2>
        <p>As a coach, you aren't diagnosing, but you are <strong>screening</strong> (the 'S' in S.T.A.B.L.E.). Standard "normal" ranges for liver enzymes are often too broad. For metabolic optimization, we look for tighter clusters.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Conventional "Normal"</th>
                        <th>Metabolic Optimal</th>
                        <th>Coaching Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>ALT (Alanine Aminotransferase)</td>
                        <td>0 - 45 U/L</td>
                        <td>10 - 25 U/L</td>
                        <td>Primary marker of liver cell stress/fat.</td>
                    </tr>
                    <tr>
                        <td>AST/ALT Ratio</td>
                        <td>N/A</td>
                        <td>< 0.8</td>
                        <td>Ratio > 1 may indicate advanced fibrosis or alcohol.</td>
                    </tr>
                    <tr>
                        <td>GGT (Gamma-Glutamyl Transferase)</td>
                        <td>0 - 60 U/L</td>
                        <td>< 20 U/L</td>
                        <td>Marker of oxidative stress and fatty liver.</td>
                    </tr>
                    <tr>
                        <td>Uric Acid</td>
                        <td>3.5 - 7.2 mg/dL</td>
                        <td>4.0 - 5.5 mg/dL</td>
                        <td>Surrogate for high fructose/purine intake.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>The <strong>Fatty Liver Index (FLI)</strong> is a validated algorithm you can use with client data. It requires BMI, Waist Circumference, Triglycerides, and GGT. An FLI score > 60 indicates a high probability (85%+) of NAFLD. Even without the full formula, seeing high Triglycerides (>150 mg/dL) paired with high ALT (>30 U/L) should immediately trigger a hepatic-focused strategy.</p>

        <h2 id="choline">4. The Export Problem: Choline and Methionine Metabolism</h2>
        <p>Fat doesn't just "sit" in the liver; it is supposed to be exported as <strong>VLDL (Very Low-Density Lipoprotein)</strong>. For the liver to package triglycerides into VLDL, it requires <span class="highlight">Phosphatidylcholine</span>. If a client is deficient in choline or the methyl donors (like methionine, B12, and Folate) needed to produce it via the PEMT pathway, fat becomes "trapped" in the liver.</p>

        <p>A 2023 study published in <em>The Journal of Nutrition</em> demonstrated that individuals with the lowest choline intake had a 28% higher risk of NAFLD. This is why low-fat, high-carb diets often worsen fatty liver; they provide the substrate for fat (sugar) while removing the source of export (choline found in egg yolks and meat).</p>

        <h2 id="defatting">5. Strategies for 'De-fatting' the Liver</h2>
        <p>To restore systemic insulin sensitivity, we must prioritize hepatic clearance. This is the "Bio-Hacking" phase of the Lifestyle Reset. The following hierarchy of interventions is most effective:</p>

        <div class="key-terms-box">
            <p class="box-label">The Hepatic Clearance Protocol</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Aggressive Fructose Restriction</p>
                    <p class="definition">Eliminating HFCS and limiting fruit to 1-2 servings/day to stop the DNL "tap."</p>
                </div>
                <div class="term-item">
                    <p class="term">Time-Restricted Feeding (TRF)</p>
                    <p class="definition">A 16:8 window allows the liver to switch from "storage mode" to "oxidation mode."</p>
                </div>
                <div class="term-item">
                    <p class="term">Choline & Cruciferous Support</p>
                    <p class="definition">Increasing eggs and sulforaphane-rich foods to aid VLDL export and Phase II detox.</p>
                </div>
                <div class="term-item">
                    <p class="term">Resistance Training</p>
                    <p class="definition">Creating a "glucose sink" in the muscle to prevent further overflow to the liver.</p>
                </div>
            </div>
        </div>

        <h2 id="clinical">6. Restoring the First-Phase Insulin Response</h2>
        <p>One of the most profound consequences of NAFLD is the loss of the <strong>First-Phase Insulin Response</strong>. Normally, the pancreas releases a "burst" of insulin within minutes of eating to signal the liver to stop glucose production. In hepatic insulin resistance, the liver ignores this signal.</p>

        <p>By "de-fatting" the liverâ€”even by as little as 5-10%â€”we can often restore this first-phase response. This results in much lower post-prandial (after meal) blood sugar spikes. A 1-gram reduction in liver fat can lead to a 20% improvement in hepatic insulin sensitivity.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Why does fructose drive fatty liver more aggressively than glucose?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Fructose is metabolized almost exclusively in the liver and lacks a rate-limiting enzyme (phosphofructokinase). This forces the liver to convert the excess substrate into fat via De Novo Lipogenesis (DNL) and generates uric acid, which impairs mitochondrial function.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">How does choline deficiency contribute to NAFLD?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Choline is required to synthesize Phosphatidylcholine, a key component of VLDL particles. Without sufficient choline, the liver cannot package and export triglycerides, causing them to accumulate in the hepatocytes.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The <strong>Overflow Hypothesis</strong> posits that liver fat is the primary driver of systemic insulin resistance once subcutaneous fat cells are full.</li>
                <li><strong>Hepatic DAGs</strong> activate PKC-Îµ, which blocks the insulin signaling pathway in the liver.</li>
                <li><strong>Uric acid</strong> is a metabolic byproduct of fructose that drives oxidative stress and mitochondrial dysfunction.</li>
                <li>Optimal ALT levels for metabolic health are <strong>10-25 U/L</strong>; values higher than this suggest hepatic stress.</li>
                <li>Restoring the liver's insulin sensitivity is the fastest way to stabilize fasting blood glucose levels.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Petersen, K.F., et al. (2021). "The role of hepatic steatosis in the pathogenesis of type 2 diabetes." <em>Journal of Clinical Investigation.</em></li>
                <li>Lustig, R.H., et al. (2022). "Fructose: Itâ€™s Alcohol Without the Buzz." <em>Advances in Nutrition.</em></li>
                <li>Shulman, G.I. (2023). "Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease." <em>N Engl J Med.</em></li>
                <li>Yoon, E.L., et al. (2022). "Non-alcoholic fatty liver disease and the risk of diabetes: a systematic review." <em>Liver International.</em></li>
                <li>Spencer, M.D., et al. (2021). "Association between choline intake and non-alcoholic fatty liver disease." <em>American Journal of Clinical Nutrition.</em></li>
                <li>Taylor, R. (2022). "Calorie restriction and the reversal of Type 2 Diabetes: The Twin Cycle Hypothesis." <em>Diabetologia.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Diabetes & Blood Sugar Coach Certification | Module 15 | Lesson 6</p>
        </footer>
    </div>
</body>

</html>